Docoh
Loading...

ANPC AnPac Bio-Medical Science

Filed: 8 Mar 21, 6:04am

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2021

 

Commission File Number: 001-39137

 

AnPac Bio-Medical Science Co., Ltd.
(Registrant’s name)

 

801 Bixing Street, Bihu County

Lishui, Zhejiang Province 323006

The People’s Republic of China
(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x  Form 40-F o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (7): o

 

 

 


 

EXHIBIT INDEX

 

Exhibit Number

 

Description

 

 

 

Exhibit 99.1

 

AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

AnPac Bio-Medical Science Co., Ltd.

 

 

(Registrant)

 

 

 

 

 

 

Date: March 8, 2021

By:

/s/ Chris Chang Yu

 

Name:

Dr. Chris Chang Yu

 

Title:

Chairman of the Board of Directors and Chief Executive Officer

 

3